Article Details
Retrieved on: 2018-04-16 22:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>France's top drugmaker, Sanofi, has entered exclusive talks with private equity firm Advent International over the sale of its European generics business for €1.9bn (£1.6bn). The global investor has made a binding and fully financed offer for Zentiva, and Sanofi said the deal is expected to close by the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here